Research study Program year 2020 Source: CMS Open Payments

Ta103-2004

Research payments

$200,745

6 payments

Through program year 2020, $200,745 in research payments was reported against Ta103-2004, across 6 payments, paid by Taro Pharmaceuticals USA, Inc..

Paid by: Taro Pharmaceuticals USA, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$200,745	6

Breakdown

Who paid Research payments · program year 2020

Taro Pharmaceuticals USA, Inc. $200,745 6 payments

Who received the money Research payments · program year 2020

Dfw Clinical Research Organisation paid for research $133,650 3 payments
3A Research, LLC Organisation paid for research $67,095 3 payments

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program year 2020

Professional salary support $200,745 6 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

2 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.